Health-care companies rose amid deal activity.
Health-care conglomerate Johnson & Johnson has struck a $13.1 billion deal to buy Shockwave Medical, strengthening its hand in the cardiovascular field.
Swiss drug giant Novartis's latest data on its Pluvicto prostate-cancer therapy clears a path to seek regulatory approval for an expanded label, said analysts at brokerage UBS.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
04-05-24 1743ET